Home
Scholarly Works
Is SABR Cost-Effective in Oligometastatic Cancer?...
Conference

Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-Comet

Authors

Qu MX; Chen Y; Zaric G; Senan S; Olson RA; Harrow S; John-Baptiste A; Gaede S; Mulroy L; Schellenberg D

Volume

105

Pagination

pp. s100-s101

Publisher

Elsevier

Publication Date

September 1, 2019

DOI

10.1016/j.ijrobp.2019.06.586

Conference proceedings

International Journal of Radiation Oncology • Biology • Physics

Issue

1

ISSN

0360-3016

Contact the Experts team